3-Aryloxy-3-aryl-propaneamines and their method of use

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

26050118, 26050119, 424330, 564220, 564346, 564347, 564355, A01N 3730, A61K 31135, C07C 9302

Patent

active

042961262

ABSTRACT:
Novel benzene-propanamines of the formula ##STR1## wherein X is selected from the group consisting of hydrogen, chlorine, fluorine and bromine, R.sub.1 is selected from the group consisting of hydrogen and alkyl of 1 to 5 carbon atoms, R.sub.2 is alkyl of 1 to 5 carbon atoms, R.sub.3 is selected from the group consisting of hydrogen, chlorine, bromine, --CF.sub.3, methyl and methoxy when R.sub.4 is nitro and R.sub.3 is selected from the group consisting of amino and acetamido when R.sub.4 is hydrogen and their non-toxic, pharmaceutically acceptable acid addition salts having anorexigenic activity and inhibit serotonine uptake in vivo and in vitro and their preparation.

REFERENCES:
patent: 2683742 (1954-07-01), Cusic
patent: 3106564 (1963-10-01), Fleming et al.
patent: 3496195 (1970-02-01), Ecsery et al.
patent: 4018895 (1977-04-01), Molloy et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

3-Aryloxy-3-aryl-propaneamines and their method of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-Aryloxy-3-aryl-propaneamines and their method of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-Aryloxy-3-aryl-propaneamines and their method of use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1491352

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.